Arvee Laboratories (India) Ltd. (NSE:ARVEE)

India · Delayed Price · Currency is INR

170.70

+7.43 (4.55%)

Apr 29, 2026, 3:29 PM IST

19.97% (1Y)

Market Cap	1.86B
Revenue (ttm)	271.60M
Net Income (ttm)	20.75M
Shares Out	11.02M
EPS (ttm)	1.88
PE Ratio	89.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	720
Average Volume	2,904
Open	174.99
Previous Close	163.27
Day's Range	166.90 - 174.99
52-Week Range	129.11 - 290.78
Beta	0.58
RSI	57.06
Earnings Date	May 7, 2026

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinit... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 2012

Employees 70

Stock Exchange National Stock Exchange of India

Ticker Symbol ARVEE

Full Company Profile

Financial Performance

In fiscal year 2025, NSE:ARVEE's revenue was 384.87 million, an increase of 26.83% compared to the previous year's 303.45 million. Earnings were 21.47 million, an increase of 104.15%.

Financial Statements

News

There is no news available yet.